I have 10 years of experience and specialize in the field of clinical drug development, with specific knowledge of lipid metabolism, atherosclerosis and diabetes. I have published on such topics as clinical trials of novel lipid-lowering agents and the utility of biomarkers of atherosclerosis. I have testified on pharmaceutical clinical development programs.